With rising global diabetes cases and biosimilar acceptance, the insulin biosimilars market is expanding fast—fueled by R&D, accessibility, and strategic alliances. https://www.einpresswire.com/article/833971141/insulin-biosimilars-market-set-to-double-by-2033-led-by-novel-partnerships-and-facility-expansions